Opportunity Information: Apply for RFA HG 20 046
The National Institutes of Health (NIH) announced this funding opportunity (RFA-HG-20-046) to create a Genomic Variation and Function Data and Administrative Coordinating Center (DACC) for the Impact of Genomic Variation on Function (IGVF) Consortium. In plain terms, the award is meant to stand up a central hub that keeps the IGVF Consortium running smoothly and makes sure the data and outputs produced across the consortium become a well-organized, usable community resource. The activity is in the health category (CFDA 93.172) and uses a U24 cooperative agreement mechanism, which generally means the NIH will have substantial involvement in ongoing oversight and coordination rather than operating as a fully hands-off funder. Clinical trials are not allowed under this announcement.
The core mission of the DACC is twofold: (1) data and resource coordination and (2) administrative and scientific coordination across the consortium. On the data side, the DACC is responsible for establishing and maintaining a resource that brings together consortium-generated data, metadata, methods, and tools. That implies building (or operating) systems and standards so that outputs from multiple IGVF projects can be consistently submitted, described, validated, tracked, and accessed. The emphasis on metadata, methods, and tools signals that NIH is not looking for a simple file repository; the DACC is expected to capture the context needed for reuse, including experimental details, processing pipelines, quality metrics, and software or analytic approaches that allow other scientists to interpret and reproduce results.
On the consortium coordination side, the DACC serves as the operational backbone for IGVF activities. This includes coordinating consortium meetings and communications, supporting cross-site planning, aligning data collection strategies, and helping different consortium components work toward shared milestones. The FOA also makes clear that the DACC is expected to facilitate consortium-led analyses, meaning it should help enable integrative or comparative analyses that span multiple datasets and projects. In addition, the DACC must support outreach to the broader research community, which usually involves activities like documentation, user support, training materials, webinars or workshops, and generally making sure the resource is discoverable and usable beyond the immediate consortium members.
The scientific purpose behind all of this coordination is to accelerate understanding of how genomic variation affects biological function and, ultimately, human health and disease. IGVF is aimed at moving from variant discovery to functional interpretation, so a central coordinating center is critical for harmonizing how functional data are generated, represented, and analyzed. By working closely with all IGVF Consortium components, the DACC is positioned to promote consistent standards, reduce duplication, and make it easier to combine results across sites, assays, and analysis methods.
Eligibility is broad and includes many common U.S.-based applicant types: state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized governments; public housing authorities/Indian housing authorities; nonprofits (with or without 501(c)(3) status, other than institutions of higher education); for-profit organizations other than small businesses; and small businesses. The FOA explicitly highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, Indian/Native American Tribal Governments other than federally recognized, and U.S. territories or possessions.
Foreign eligibility is more restrictive. Non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply as the primary applicant, and non-domestic components of U.S. organizations are not eligible to apply. However, foreign components are allowed as defined in the NIH Grants Policy Statement, which generally means a U.S. applicant may include certain foreign collaborations or performance sites when they are well-justified and meet NIH policy requirements.
Key administrative details included in the posting are that the sponsoring agency is NIH, the opportunity is discretionary, and the original closing date listed was November 4, 2020, with a creation date of August 3, 2020. The listing does not provide an award ceiling or the expected number of awards in the excerpt provided, but it does clearly define the central deliverable: a functioning, consortium-integrated Data and Administrative Coordinating Center that can manage IGVF data resources, coordinate consortium operations, support cross-consortium analyses, and engage the broader research community with high-quality, reusable genomic variation and functional genomics resources.Apply for RFA HG 20 046
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Genomic Variation and Function Data and Administrative Coordinating Center (U24 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.172.
- This funding opportunity was created on 2020-08-03.
- Applicants must submit their applications by 2020-11-04. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: FY2020 Historic Preservation Fund - Underrepresented Community Grants
Previous opportunity: NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA HG 20 046
Applicants also applied for:
Applicants who have applied for this opportunity (RFA HG 20 046) also looked into and applied for these:
| Funding Opportunity |
|---|
| Defining Genomic Influence on Gene Network Regulation (U01 Clinical Trial Not Allowed) Apply for RFA HG 20 044 Funding Number: RFA HG 20 044 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Single-cell Profiling of Regulatory Element and Gene Activity in Relationship to Genome Function (UM1 Clinical Trial Not Allowed) Apply for RFA HG 20 045 Funding Number: RFA HG 20 045 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Developing Predictive Models of the Impact of Genomic Variation on Function (U01 Clinical Trial Not Allowed) Apply for RFA HG 20 047 Funding Number: RFA HG 20 047 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Systematic Characterization of Genomic Variation on Genomic Function and Phenotype (UM1 Clinical Trial Not Allowed) Apply for RFA HG 20 043 Funding Number: RFA HG 20 043 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Practice-Based Suicide Prevention Research Centers (P50 Clinical Trial Optional) Apply for PAR 20 286 Funding Number: PAR 20 286 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Mechanisms of Pathological Spread of Abnormal Proteins in LBD and FTD (R01 Clinical Trial Not Allowed) Apply for RFA NS 21 006 Funding Number: RFA NS 21 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Clinical Trial Planning Grant (R34 Clinical Trials Not Allowed) Apply for PAR 20 270 Funding Number: PAR 20 270 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required) Apply for RFA TR 20 003 Funding Number: RFA TR 20 003 Agency: National Institutes of Health Category: Health Funding Amount: $3,000,000 |
| Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed) Apply for PAR 20 263 Funding Number: PAR 20 263 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed) Apply for PAR 20 264 Funding Number: PAR 20 264 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional) Apply for RFA MH 20 600 Funding Number: RFA MH 20 600 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed) Apply for RFA AG 21 020 Funding Number: RFA AG 21 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required) Apply for RFA AG 21 021 Funding Number: RFA AG 21 021 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Mechanisms of Selective Vulnerability in LBD and FTD (R01 Clinical Trial Not Allowed) Apply for RFA NS 21 007 Funding Number: RFA NS 21 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed) Apply for PAR 20 259 Funding Number: PAR 20 259 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Disseminating and Implementing Patient-Centered Outcomes Research (PCOR) Evidence into Practice through Interoperable Clinical Decision Support Apply for PA 20 074 Funding Number: PA 20 074 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $1,000,000 |
| Mentored Career Development Program (K01) for Early Stage Investigators Using Nonhuman Primate Research Models (K01 Independent Clinical Trial Not Allowed) Apply for PAR 20 258 Funding Number: PAR 20 258 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA TR 20 030 Funding Number: RFA TR 20 030 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| HeartShare: Next-Generation Phenomics to Define Heart Failure Subtypes (U01 Clinical Trial Not Allowed) Apply for RFA HL 21 015 Funding Number: RFA HL 21 015 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed) Apply for PAR 21 024 Funding Number: PAR 21 024 Agency: National Institutes of Health Category: Health Funding Amount: $2,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA HG 20 046", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
